Verastem, Inc. - Common Stock — Bilan (NASDAQ:VSTM)

Afficher le graphique complet Full chart

Financials

Total de l'actif 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Total du passif 39.08 M21.1 M47.66 M71.19 M130.43 M189.25 M Total des capitaux propres 115.27 M87.56 M47.39 M57.37 M-28.89 M57.2 M Total du passif et des capitaux propres 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Dette totale 19.05 M249 K24.8 M40.09 M40.72 M76.33 M Dette nette -128.45 M-100.05 M-63.1 M-97.04 M-48.08 M-128.67 M

Verastem, Inc. - Common Stock

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem, Inc. - Common Stock

Nouvelles

Verastem Oncology nomme Michael Bailey à son conseil d’administration

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/22/26 - TipRanks.com

Cancer Stocks That Are Advancing the Future of Oncology Care

Verastem (VSTM) Loses 34.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Verastem, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:VSTM) 2026-05-09

BTIG abaisse l’objectif de cours de Verastem à 18$ après des revenus décevants

Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates

Vectoring In On Verastem (NASDAQ:VSTM)

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

H.C. Wainwright réitère sa recommandation sur Verastem suite à des données d’essai durables

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

L’action Verastem maintient sa recommandation d’achat chez BTIG grâce à des données d’essai durables